A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated Diarrhea
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Approximately 520 patients will be entered into this study taking place throughout Australia
and Europe. This study aims to determine if an investigational drug is safe and effective for
treating symptoms of C. difficile-associated diarrhea (CDAD) and lowering the risk of repeat
episodes of CDAD. The investigational drug will be evaluated in comparison to current
standard antibiotic treatment, so all patients will receive active medication. All study
related care is provided including doctor visits, physical exams, laboratory tests, and study
medication. The total length of participation is approximately 6 weeks.